139 related articles for article (PubMed ID: 10737386)
21. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.
Jamieson S; Alexiadis M; Fuller PJ
Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971
[TBL] [Abstract][Full Text] [Related]
22. Regulation of the nucleotide state of oncogenic ras proteins by nucleoside diphosphate kinase.
Fischbach MA; Settleman J
Methods Enzymol; 2006; 407():33-45. PubMed ID: 16757312
[TBL] [Abstract][Full Text] [Related]
23. GTPase stimulation in shrimp Ras(Q(61)K) with geranylgeranyl pyrophosphate but not mammalian GAP.
Chang KC; Chuang NN
J Exp Zool; 2001 Nov; 290(6):642-51. PubMed ID: 11748613
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
[TBL] [Abstract][Full Text] [Related]
25. The C-terminal end of R-Ras contains a focal adhesion targeting signal.
Furuhjelm J; Peränen J
J Cell Sci; 2003 Sep; 116(Pt 18):3729-38. PubMed ID: 12890755
[TBL] [Abstract][Full Text] [Related]
26. Mutations of K-ras oncogene in human adrenal tumours in Taiwan.
Lin SR; Tsai JH; Yang YC; Lee SC
Br J Cancer; 1998 Apr; 77(7):1060-5. PubMed ID: 9569040
[TBL] [Abstract][Full Text] [Related]
27. A functional assay for heterozygous mutations in the GTPase activating protein related domain of the neurofibromatosis type 1 gene.
Ishioka C; Ballester R; Engelstein M; Vidal M; Kassel J; The I; Bernards A; Gusella JF; Friend SH
Oncogene; 1995 Mar; 10(5):841-7. PubMed ID: 7898926
[TBL] [Abstract][Full Text] [Related]
28. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
29. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study.
Slebos RJ; Hoppin JA; Tolbert PE; Holly EA; Brock JW; Zhang RH; Bracci PM; Foley J; Stockton P; McGregor LM; Flake GP; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1223-32. PubMed ID: 11097231
[TBL] [Abstract][Full Text] [Related]
30. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
Hu W; Feng Z; Tang MS
Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic insertional mutations in the P-loop of Ras are overactive in MAP kinase signaling.
Klockow B; Ahmadian MR; Block C; Wittinghofer A
Oncogene; 2000 Nov; 19(47):5367-76. PubMed ID: 11103938
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a novel oncogenic K-ras mutation in colon cancer.
Akagi K; Uchibori R; Yamaguchi K; Kurosawa K; Tanaka Y; Kozu T
Biochem Biophys Res Commun; 2007 Jan; 352(3):728-32. PubMed ID: 17150185
[TBL] [Abstract][Full Text] [Related]
33. Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice.
Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
Oncogene; 2007 Jun; 26(30):4415-27. PubMed ID: 17297472
[TBL] [Abstract][Full Text] [Related]
34. K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancer.
Plowman SJ; Berry RL; Bader SA; Luo F; Arends MJ; Harrison DJ; Hooper ML; Patek CE
J Exp Clin Cancer Res; 2006 Jun; 25(2):259-67. PubMed ID: 16918139
[TBL] [Abstract][Full Text] [Related]
35. A novel N-ras mutation in malignant melanoma is associated with excellent prognosis.
Demunter A; Ahmadian MR; Libbrecht L; Stas M; Baens M; Scheffzek K; Degreef H; De Wolf-Peeters C; van Den Oord JJ
Cancer Res; 2001 Jun; 61(12):4916-22. PubMed ID: 11406571
[TBL] [Abstract][Full Text] [Related]
36. Persistence of K-ras mutations in plasma after colorectal tumor resection.
Lindforss U; Zetterquist H; Papadogiannakis N; Olivecrona H
Anticancer Res; 2005; 25(1B):657-61. PubMed ID: 15816642
[TBL] [Abstract][Full Text] [Related]
37. ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum.
Garrett AP; Ng SW; Muto MG; Welch WR; Bell DA; Berkowitz RS; Mok SC
Gynecol Oncol; 2000 Apr; 77(1):105-11. PubMed ID: 10739698
[TBL] [Abstract][Full Text] [Related]
38. K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke.
Yao R; Wang Y; D'Agostini F; Izzotti A; Lubet RA; You M; De Flora S
Exp Lung Res; 2005 Mar; 31(2):271-81. PubMed ID: 15824025
[TBL] [Abstract][Full Text] [Related]
39. GAP control: regulating the regulators of small GTPases.
Bernards A; Settleman J
Trends Cell Biol; 2004 Jul; 14(7):377-85. PubMed ID: 15246431
[TBL] [Abstract][Full Text] [Related]
40. K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.
Etienne-Grimaldi MC; Formento JL; Francoual M; François E; Formento P; Renée N; Laurent-Puig P; Chazal M; Benchimol D; Delpero JR; Letoublon C; Pezet D; Seitz JF; Milano G
Clin Cancer Res; 2008 Aug; 14(15):4830-5. PubMed ID: 18676755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
